By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Pulsatilla nigricans

CheckAnalogsComparePrices in pharmacies:
Can't order it
Sound forms: Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs Is required PRO account or access to audio drugs
ⓘ Learn more about digital audio preparations

Performance statistics based

X
 
  • 7
    Chest: E 53%, I 12%, 154 cases. 957 meds
    • 14
      Abdomen: E 45%, I 12%, 231 case. 1010 meds
      • 4
        Pelvis: E 60%, I 12%, 40 cases. 423 meds
        • 8
          Back: E 45%, I 11%, 145 cases. 818 meds
          • 17
            Limbs: E 36%, I 11%, 425 cases. 890 meds
            • 155
              Diseases: E 36%, I 10%, 594 cases. 1803 meds
              • 5
                Cardiovascular system: E 39%, I 10%, 282 cases. 1060 meds
                • 43
                  Common symptoms: E 33%, I 9%, 26 cases. 702 meds
                  • 12
                    Respiratory system: E 42%, I 8%, 518 cases. 935 meds
                    • 9
                      Bone system: E 39%, I 8%, 266 cases. 240 meds
                      • 17
                        Psyche: E 26%, I 7%, 762 cases. 1248 meds
                        • 17
                          Digestive system: E 31%, I 7%, 669 cases. 1228 meds
                          • 17
                            Head: E 35%, I 6%, 697 cases. 1188 meds
                            • 22
                              Skin: E 33%, I 6%, 545 cases. 1191 meds
                              • 8
                                Anamnesis: E 29%, I 5%, 224 cases. 640 meds
                                • 6
                                  Genitourinary system: E 33%, I 4%, 306 cases. 366 meds
                                  • 14
                                    The muscular system: E 37%, I 4%, 117 cases. 209 meds
                                    • 8
                                      Down neck: E 27%, I 4%, 146 cases. 685 meds
                                      • 10
                                        Nervous system: E 35%, I 3%, 168 cases. 485 meds
                                        • 6
                                          Tests: E 28%, I 1%, 190 cases. 834 meds

                                          Last updated date: 21.05.2024

                                          Instructions
                                          The personalized statistics of Kiberis assesses the importance of symptoms for drugs and the effectiveness of treatment of symptoms and diseases, taking into account the individuality of each patient.
                                          The data is grouped by meaning in the form of a repertory. The atlas displays the most significant organs for this drug.
                                          E - Efficiency. How much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) is negative, because the patient will get worse over time.
                                          I - The effect of the symptom on the overall outcome of the patient's treatment (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
                                          Available only when using PRO account
                                          Content moderator: Vasin A. S.


                                          1. Kiberis is NOT an online store and does NOT purchase, store, sell or deliver drugs. The resource acts only as an intermediary between you and the manufacturer of drugs or pharmacy points, which carry out the delivery.
                                          2. On Kiberis there are descriptions of drugs, some of which are intended only for doctors. This information cannot be used by patients to make decisions about the use of drugs, their cancellation or correction of dosages.
                                          3. Nothing in the information provided should be interpreted as a call to use these drugs.
                                          4. No claims can be made to Kiberis regarding any damage or harm incurred as a result of the use of the information posted on the site.